The Hoover Institution fellow and White House COVID-19 advisor drew fire earlier this week for urging Michigan residents to stand up against further lockdowns. 

When Amazon opened the doors of its drugstore business Nov. 17, the potential competitive ramifications rattled that industry on many levels. Would establishment drug sellers stand a chance against the mighty retail innovator?

RSNA's COVID-19 Task Force is now looking to better understand the factors that go into patients’ decisions to seek, or delay, imaging care. 

Radiologist and Allison Breast Center owner Michael Bigg is being sued by six women over wrongly interpreted scans. 

A healthcare startup whose AI-powered symptom checker lets users check symptoms against other patients’ experiences has begun a partnership with Mayo Clinic and raised a fresh $42 million to advance its telehealth platform.  

Drug therapy is typically recommended for the initial treatment of patients with atrial fibrillation, but new research suggests there could be a more effective way. 

The finding is part of a new report from the American College of Radiology’s Task Force on Certification. 

Despite those similarities, EVALI and the novel coronavirus require very different treatments.

A new company called DeliverHealth Solutions is forming to service clients of Nuance’s HIM transcription and EHR go-live businesses.

Treatment with empagliflozin for six months was associated with several key improvements. This suggests that, yes, SGLT2 inhibitors can be recommended for HFrEF patients who don't have diabetes.